We provide you with 20 years of free, institutional-grade data for CMRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CMRX. Explore the full financial landscape of CMRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Chimerix, Inc(NASDAQ:CMRX) 
Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candi...
Website: http://www.chimerix.com
Founded: 2000
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CMRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.